Inspire Medical Systems, Inc. INSP
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 102.78% | -108.30% | 1,270.22% | 376.50% | -220.05% |
| Total Depreciation and Amortization | -10.04% | 33.70% | 3.94% | 7.70% | 12.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.02% | 153.05% | -305.55% | -35.10% | 48.10% |
| Change in Net Operating Assets | -74.16% | 51.18% | -205.55% | 159.78% | 1.96% |
| Cash from Operations | 80.78% | -75.51% | -23.43% | 2,453.13% | 140.04% |
| Capital Expenditure | 5.82% | 8.73% | -2.08% | -16.03% | -7.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 934.41% | -20.68% | -4.64% | -102.17% | 710.61% |
| Cash from Investing | 131.54% | 5.61% | -2.34% | -125.01% | 3,098.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,281.65% | -95.45% | 590.78% | -93.61% | -15.71% |
| Repurchase of Common Stock | 90.98% | 85.03% | 1.40% | -2,869.11% | 98.16% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 125.54% | 84.51% | 5.42% | -1,481.61% | 104.21% |
| Foreign Exchange rate Adjustments | 14,100.00% | 100.36% | -339.13% | 12.75% | 140.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 590.21% | 26.78% | -235.72% | -88.84% | 155.10% |